Colgate and Verily formed a partnership to start a study to assess whether better oral health will lead to other health improvements.
Alphabet’s life science spin-off companies Verily and Colgate-Palmolive are Initiate an investigation The link between oral health and cardiometabolic health. The two companies plan to recruit 200 participants from Verily’s baseline health study, an extensive study that collects data from thousands of patient volunteers.
Participants will be divided equally into a control group and an intervention group. Both will undergo preliminary deep cleaning at the Adams School of Dentistry at the University of North Carolina at Chapel Hill. For 18 months, patients in the intervention group will use Colgate dental irrigators and smart toothbrushes, while the control group will not receive any additional equipment during the study.
Finally, the participants’ oral health, changes in blood sugar and blood flow-mediated dilation will be assessed. Flow-mediated dilation is a measure of the degree of arterial dilation when blood flow increases.
The goal is to see if people’s overall health has improved by improving their oral health.
“We have long known that oral health, cardiovascular disease, and diabetes are interrelated. “The combination of the depth of biometrics in the baseline health study and the dental expertise of the UNC Adams School of Dentistry and Colgate will allow us to significantly expand our knowledge. Library,” said Dr. Rob Califf, head of clinical policy at Verily and Google Health, in the press release.
This collaboration is only part of Verily’s broader effort to establish its research platform.company Recently hired Amy Abernethy, The former acting chief information officer of the US Food and Drug Administration, serving as the president of its clinical research business.
